England will be the first country to vaccinate against gonorrhoea, initiating a program in August primarily for gay and bisexual men with risky sexual behaviors. The intramuscular vaccine, derived from the meningitis B vaccine and shown to reduce gonorrhoea cases by 30-40%, aims to counteract the unprecedented rise in infections, which surpassed 85,000 in 2023. Health advocates anticipate that a successful uptake could prevent 100,000 cases and save the NHS significant costs within a decade. However, it wonât eliminate risk, highlighting the need for ongoing safe sex practices.
The roll-out of the gonorrhoea vaccine in England, targeting high-risk individuals, aims to address the record levels of infections and alleviate NHS pressure.
The vaccine, although only 30-40% effective, could prevent up to 100,000 gonorrhoea cases and save the NHS nearly £8 million over the next decade.
Max, a sexual health campaigner, expressed strong support for the vaccine, stating that it would significantly alleviate the burden on sexual health clinics.
Despite being derived from the meningitis B vaccine, the jab will not completely eliminate the risk of gonorrhoea, necessitating awareness during treatment discussions.
Collection
[
|
...
]